For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Augsburg D-86150

0 studies enrolling now · 8 studies all time

What they study most

Colorectal Cancer, Erectile Dysfunction, Impotence, Non-Small Cell Lung Cancer, Prostate Cancer, Psoriasis, Sepsis

Studies at this site

• A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) — Completed
• Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer — Completed
• A Study in Second Line Metastatic Colorectal Cancer — Completed
• A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy — Completed
• A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer — Completed
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock — Completed
• A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes. — Completed
• Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life — Completed